Pharmacological treatment at discharge was also analyzed including antiplatelet- and heart failure-focused therapy (beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, mineralocorticoid receptor antagonists, diuretics). This evidence concerns the gene ACE and heart failure.